Ann: Cholesterol-Lowering Program Update, page-39

$6.5 cash at end of march, likely spent $3-3.5m this quarter… so I’d say $3-3.5m cash left best case.. however, cash outflows will fall with one program progressing for now. I’d put cash backing at something closer to 2.5 c per share. CR will be required by Christmas, will they have anything to pitch to the market? TBI is still in the game for now but market is putting that at something between 1 in 100 and nil chance of making it through toxicology IMHO.. definitely punt territory here.. I’ll wait and see if has one more capitulation day and can snag in the 2’s though I think.